Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release

A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Prado, H.J., Matulewicz, M.C., Bonelli, P.R., Cukierman, A.L.
Formato: JOUR
Materias:
pH
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado
Aporte de:
id todo:paper_00086215_v344_n11_p1325_Prado
record_format dspace
spelling todo:paper_00086215_v344_n11_p1325_Prado2023-10-03T14:07:19Z Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release Prado, H.J. Matulewicz, M.C. Bonelli, P.R. Cukierman, A.L. Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Cationized starch Controlled release Ibuprofen Interpolyelectrolyte complex Kappa-carrageenan Matrix system Dissolution Starch Turbidity Controlled drug delivery buffer ibuprofen polyelectrolyte starch article controlled drug release diffusion dissolution drug delivery system drug synthesis infrared spectroscopy measurement performance pH priority journal tablet tablet matrix turbidity Amylose Carbohydrate Sequence Carrageenan Diffusion Drug Carriers Electrolytes Ibuprofen Pharmaceutical Preparations Quaternary Ammonium Compounds Spectroscopy, Fourier Transform Infrared Starch Tablets A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some differences in comparison with either IPEC constituents or physical mixture. The swelling of tablets obtained by direct compression was independent of pH, and a maximum value of 742% was attained after 24 h. The performance of the IPEC as matrix for controlled release of ibuprofen indicates that drug delivery takes place in a zero-order manner. Experimental dissolution data in the buffer stage were properly represented by a model accounting for contributions of Fickian diffusion and relaxation phenomena; this model suggests that the former predominates over the latter, for the modeled range. © 2009 Elsevier Ltd. All rights reserved. Fil:Prado, H.J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Matulewicz, M.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Bonelli, P.R. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Cukierman, A.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Dissolution
Starch
Turbidity
Controlled drug delivery
buffer
ibuprofen
polyelectrolyte
starch
article
controlled drug release
diffusion
dissolution
drug delivery system
drug synthesis
infrared spectroscopy
measurement
performance
pH
priority journal
tablet
tablet matrix
turbidity
Amylose
Carbohydrate Sequence
Carrageenan
Diffusion
Drug Carriers
Electrolytes
Ibuprofen
Pharmaceutical Preparations
Quaternary Ammonium Compounds
Spectroscopy, Fourier Transform Infrared
Starch
Tablets
spellingShingle Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Dissolution
Starch
Turbidity
Controlled drug delivery
buffer
ibuprofen
polyelectrolyte
starch
article
controlled drug release
diffusion
dissolution
drug delivery system
drug synthesis
infrared spectroscopy
measurement
performance
pH
priority journal
tablet
tablet matrix
turbidity
Amylose
Carbohydrate Sequence
Carrageenan
Diffusion
Drug Carriers
Electrolytes
Ibuprofen
Pharmaceutical Preparations
Quaternary Ammonium Compounds
Spectroscopy, Fourier Transform Infrared
Starch
Tablets
Prado, H.J.
Matulewicz, M.C.
Bonelli, P.R.
Cukierman, A.L.
Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
topic_facet Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Cationized starch
Controlled release
Ibuprofen
Interpolyelectrolyte complex
Kappa-carrageenan
Matrix system
Dissolution
Starch
Turbidity
Controlled drug delivery
buffer
ibuprofen
polyelectrolyte
starch
article
controlled drug release
diffusion
dissolution
drug delivery system
drug synthesis
infrared spectroscopy
measurement
performance
pH
priority journal
tablet
tablet matrix
turbidity
Amylose
Carbohydrate Sequence
Carrageenan
Diffusion
Drug Carriers
Electrolytes
Ibuprofen
Pharmaceutical Preparations
Quaternary Ammonium Compounds
Spectroscopy, Fourier Transform Infrared
Starch
Tablets
description A novel cationized starch-based interpolyelectrolyte complex (IPEC) was formed using kappa-carrageenan as the counter polyion. Characterization of the product by turbidity measurements and elemental analyses indicated a 1:1 interaction of the repeating units. FT-IR spectra for the IPEC showed some differences in comparison with either IPEC constituents or physical mixture. The swelling of tablets obtained by direct compression was independent of pH, and a maximum value of 742% was attained after 24 h. The performance of the IPEC as matrix for controlled release of ibuprofen indicates that drug delivery takes place in a zero-order manner. Experimental dissolution data in the buffer stage were properly represented by a model accounting for contributions of Fickian diffusion and relaxation phenomena; this model suggests that the former predominates over the latter, for the modeled range. © 2009 Elsevier Ltd. All rights reserved.
format JOUR
author Prado, H.J.
Matulewicz, M.C.
Bonelli, P.R.
Cukierman, A.L.
author_facet Prado, H.J.
Matulewicz, M.C.
Bonelli, P.R.
Cukierman, A.L.
author_sort Prado, H.J.
title Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
title_short Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
title_full Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
title_fullStr Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
title_full_unstemmed Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
title_sort preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release
url http://hdl.handle.net/20.500.12110/paper_00086215_v344_n11_p1325_Prado
work_keys_str_mv AT pradohj preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease
AT matulewiczmc preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease
AT bonellipr preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease
AT cukiermanal preparationandcharacterizationofanovelstarchbasedinterpolyelectrolytecomplexasmatrixforcontrolleddrugrelease
_version_ 1782031019353833472